Federated Hermes’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-36,000
Closed -$188K 2184
2025
Q3
$188K Sell
36,000
-35,217
-49% -$134K ﹤0.01% 1517
2025
Q2
$246K Sell
71,217
-25,096
-26% -$74.6K ﹤0.01% 1462
2025
Q1
$252K Buy
96,313
+46,213
+92% +$181K ﹤0.01% 1460
2024
Q4
$206K Buy
50,100
+42,231
+537% +$230K ﹤0.01% 1480
2024
Q3
$55.7K Sell
7,869
-304,575
-97% -$2.28M ﹤0.01% 1637
2024
Q2
$2.04M Sell
312,444
-24,046
-7% -$164K ﹤0.01% 919
2024
Q1
$2.79M Buy
+336,490
New +$3.28M 0.01% 850
2022
Q1
Sell
-600,000
Closed -$18.4M 2290
2021
Q4
$18.4M Hold
600,000
0.03% 510
2021
Q3
$18.9M Hold
600,000
0.04% 480
2021
Q2
$22M Sell
600,000
-218,309
-27% -$7.19M 0.04% 455
2021
Q1
$28.3M Buy
818,309
+250,000
+44% +$10.9M 0.06% 408
2020
Q4
$23.6M Buy
568,309
+68,309
+14% +$3.09M 0.05% 428
2020
Q3
$21.3M Buy
+500,000
New +$19.1M 0.05% 396

Other funds holding RLAY